52W Range | $1.71-$6.31 |
Shares Short | 19,718 |
Revenue (12 Mos) | $308.7M |
Revenue Growth (YoY) | 4,399.7% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
CEO | Mr. Robert Wessman |
Address | 9, Rue de Bitbourg, Luxembourg City, Luxembourg, 1273 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 999 |